L系列抗体芯片技术的特色优势
RayBiotech L系列标记法芯片技术是基于固相载体,将不同抗体点制在载体上,通过生物素标记样本及抗原抗体特异性结合原理,结合了高通量、高灵敏度的特性,大大提高了检测样本中蛋白表达的质量。
RayBiotech新产品涵盖细胞周期,自噬,生长因子,受体相互作用,凋亡、PI3K通路等方面,仅用微量的样本就能检测大量蛋白质,为科研工作者提供一个快速、灵敏、便利分泌组研究工具!

L系列新产品样本用量

产品目录
01
Human PI3K-Akt Signaling Pathway Array L1, Glass Slide(PI3K-Akt芯片)
背景: PI-3K-AKT是细胞中一个经典的信号通路,它是一条与磷脂酰肌醇有关的信号通路,也是RTK介导衍生的信号通路。在胰岛素的刺激以及细胞生存当中发挥着重要作用。PI3K/AKT信号通路是一条与增殖,分化和凋亡相关的信号通路。PI3K是磷脂酰肌醇3-激酶,分为IA和IB两个亚型, 他们分别可以接收来自酪氨酸激酶连接受体和G蛋白偶联受体传递的信号,能够发挥类脂激酶和蛋白激酶的双重活性。AKT也叫做PKB(protein kinase B),是PI3K的下游分子,包括AKT1、AKT2和AKT3等至少3种存在形式。PI3K/Akt 信号通路失调见于多种人类疾病,包括癌症、糖尿病、心血管疾病和神经疾病。
货号:AAH-BLG-AKT
靶标数:307
靶标列表:
| 14-3-3 beta | IL-2 |
| 14-3-3 epsilon | IL-2 R alpha |
| 14-3-3 eta | IL-2 R beta |
| 14-3-3 gamma | IL-2 R gamma |
| 14-3-3 theta | IL-3 |
| 14-3-3 zeta | IL-3 R alpha |
| aFGF | IL-4 |
| AKT1 | IL-4 R |
| AKT2 | IL-6 |
| AKT3 | IL-6 R |
| Amphiregulin | IL-7 |
| AMPKa1 | IL-7 R alpha |
| Angiopoietin-1 | Insulin |
| Angiopoietin-2 | Insulin R |
| Angiopoietin-4 | IRS1 |
| ATF2 | ITGA1 |
| ATF4 | ITGA11 |
| bad | ITGA2 |
| Bcl-2 | ITGA3 |
| BCL2L1 | ITGA4 |
| BDNF | ITGA5 |
| beta-NGF | ITGA6 |
| BIM L | ITGA7 |
| BRCA1 | ITGA8 |
| CASP9 | ITGA9 |
| CCND2 | ITGAV |
| CCND3 | ITGB1 |
| CCNE1 | ITGB4 |
| CCNE2 | ITGB5 |
| CD19 | ITGB6 |
| CD41 | ITGB7 |
| CD61 | ITGB8 |
| CDC37 | JAK1 |
| CDK2 | JAK3 |
| CDK4 | KIAA1303 |
| CDK6 | LAM b1 |
| CHAD | LAMA |
| CHRM1 | LAMA2 |
| CHRM2 | LAMA3 |
| CHUK | LAMB2 |
| CO4A2 | LAMC1 |
| COL1A2 | Lamininalpha 4 |
| COL2A1 | LPAR1 |
| COL4A1 | LPAR2 |
| COL4A3 | LPAR4 |
| COL4A4 | LPAR5 |
| COL4A5 | MAGI2 |
| COL6A2 | MAP2K1 |
| COL6A3 | MAP2K2 |
| COL9A3 | MAPK1 |
| Collagen I a1 | MAPK3 |
| Collagen IVa6 | Mcl-1 |
| Collagen IX | M-CSF |
| Collagen VI | M-CSF R |
| COMP | MDM2 |
| CREB1 | MTCP1 |
| CREB3L1 | MTOR |
| CREB3L2 | MYB |
| CRTC2 | MYC |
| CSH1 | NFKB1 |
| CSH2 | NGFR |
| Cyclin D1 | NOS3 |
| EFNA1 | NR4A1 |
| EFNA3 | NRAS |
| EFNA4 | NT-3 |
| EFNA5 | NT-4 |
| EGF | NTRK1 |
| EGFR | Oncostatin M |
| EIF4B | Oncostatin M R beta |
| EIF4E | Osteopontin |
| EIF4EBP1 | p21 |
| EphA2 | p27/Kip1 |
| Epiregulin | p53 |
| ErbB2 | PAR1 |
| ErbB3 | PCK1 |
| ErbB4 | PCK2 |
| Erythropoietin | PDGF R alpha |
| Erythropoietin R | PDGF R beta |
| FAK | PDGF-AA |
| Fas Ligand | PDGF-BB |
| FGF Basic | PDGF-C |
| FGF R3 | PDGF-D |
| FGF R4 | PDPK1 |
| FGF-10 | PIK3AP1 |
| FGF-16 | PIK3CA |
| FGF-17 | PIK3CB |
| FGF-18 | PIK3CD |
| FGF-19 | PIK3CG |
| FGF-20 | PIK3R1 |
| FGF-21 | PIK3R2 |
| FGF22 | PIK3R3 |
| FGF-23 | PIK3R5 |
| FGF-3 | PIK3R6 |
| FGF-4 | PKN1 |
| FGF-5 | PKN2 |
| FGF-6 | PKN3 |
| FGF-7 | PLGF |
| FGF-8 | PPP2CA |
| FGF-9 | PPP2CB |
| FGFR1 | PPP2R1A |
| FGFR2 | PPP2R1B |
| Fibronectin | PPP2R2A |
| Flt-3 | PPP2R2B |
| Flt-3 Ligand | PPP2R2C |
| G6PC | PPP2R5C |
| GBL | PPP2R5E |
| GCSF | PRKAA2 |
| GCSF R | PRKCA |
| GNB1 | PRLR |
| GNB2 | Prolactin |
| GNB3 | PTEN |
| GNB4 | RAC1 |
| GNB5 | RAF1 |
| GNG11 | Ras |
| GNG12 | RBL2 |
| GNG13 | RELA |
| GNG4 | RELN |
| GNG5 | RHEB |
| GNG8 | RPS6 |
| GNGT1 | RPS6KB1 |
| GNGT2 | RXRA |
| GRB2 | SCF |
| Growth hormone 1 | SCF R |
| Growth hormone 2 | SGK1 |
| Growth Hormone R | SOS2 |
| GSK3B | STK11 |
| GYS1 | SYK |
| GYS2 | TCL1A |
| HGF | TCL1B |
| HGFR | Tenascin X |
| HRAS | Tenascin C |
| HSP90 | TGF alpha |
| HSP90AA1 | THBS3 |
| HSP90B1 | Thrombospondin 1 |
| IBSP | Thrombospondin-2 |
| IFN alpha 5 | Thrombospondin-4 |
| IFNA10 | Tie-2 |
| IFNA14 | TLR2 |
| IFNA16 | TLR4 |
| IFNA17 | TNN |
| IFNA2 | TNR |
| IFNA21 | TRKB |
| IFNA4 | TSC1 |
| IFNA6 | TSC2 |
| IFNA7 | VEGF-A |
| IFNA8 | VEGF-B |
| IFN-alpha / beta R2 | VEGF-C |
| IFN-alpha/beta R1 | VEGF-D |
| IFN-beta | VEGFR1 |
| IGF-1 | VEGFR2 |
| IGF-2 | VEGFR3 |
| IGF-I R | Vitronectin |
| IKBKB | VWF |
| IKBKG |
02
Human Apoptosis Array L1(人凋亡芯片)
背景:细胞凋亡(apoptosis)指为维持内环境稳定,由基因控制的细胞自主的有序的死亡。细胞凋亡与细胞坏死不同,细胞凋亡不是一件被动的过程,而是主动过程,它涉及一系列基因的激活、表达以及调控等的作用,它并不是病理条件下,自体损伤的一种现象,而是为更好地适应生存环境而主动争取的一种死亡过程。
靶标数:119
靶标列表:
| AIF | GZMB |
| AKT1 | HRAS |
| AKT2 | HTRA2 |
| AKT3 | IKBKB |
| Alpha Fodrin | IKBKG |
| alpha Tubulin | IL-3 |
| APAF1 | IL-3 R alpha |
| ASK1 | IRE1 |
| ATF4 | JUN |
| ATM | Livin |
| bad | LMNA |
| BAK1 | LMNB1 |
| bax | LMNB2 |
| Bcl-2 | MAP2K1 |
| BCL2L1 | MAP2K2 |
| BECN1 | MAP3K14 |
| beta-NGF | MAPK1 |
| BID | MAPK3 |
| BIM L | MAPK8 |
| BIRC2 | MAPK9 |
| BIRC6 | Mcl-1 |
| BOK | NFKB1 |
| Calpain 1 | NFKBIA |
| CASP10 | NGFR |
| CASP2 | Non-muscle Actin |
| CASP6 | NRAS |
| CASP7 | NTRK1 |
| CASP9 | p53 |
| Caspase-3 | PARP1 |
| Caspase-8 | PARP4 |
| Cathepsin B | PDPK1 |
| Cathepsin D | PIK3CA |
| Cathepsin H | PIK3CB |
| Cathepsin L | PIK3CD |
| Cathepsin S | PIK3R1 |
| Cathepsin Z | PIK3R2 |
| CFLAR | PIK3R3 |
| CHUK | PRF1 |
| cIAP-2 | PTPN13 |
| CSF2RB | RAF1 |
| CTSF | Ras |
| CTSK | RELA |
| CTSO | RIP1 |
| CTSV | SMAC |
| CTSW | Survivin |
| Cytochrome C (d) | TNF alpha |
| DAXX | TNF RI |
| DDIT3 | TRADD |
| DFF45 | TRAF1 |
| DFFB | TRAF2 |
| DPPI | TRAIL |
| EIF2AK3 | TRAIL R1 |
| EIF2S1 | TRAIL R2 |
| FADD | TUBA1A |
| Fas | TUBA1B |
| Fas Ligand | TUBA6 |
| FOS | TUBA8 |
| GADD45A | TUBAL3 |
| GADD45B | XIAP |
| GADD45G |
03
背景:自噬是一个吞噬自身细胞质蛋白或细胞器并使其包被进入囊泡,并与溶酶体融合形成自噬溶酶体,降解其所包裹的内容物的过程,借此实现细胞本身的代谢需要和某些细胞器的更新。自噬在机体的生理和病理过程中都能见到,其所起的作用是正面还是负面的尚未完全阐明,对肿瘤的研究尤其如此,值得关注。
货号:AAH-BLG-AUT
靶标数:104
靶标列表:
| AKT1 | MAPK8 |
| AKT1S1 | MAPK9 |
| AKT2 | MRAS |
| AKT3 | MTOR |
| AMBRA1 | NRAS |
| AMPKa1 | NRBF2 |
| ATG10 | PDPK1 |
| ATG12 | PIK3C3 |
| ATG13 | PIK3CA |
| ATG14 | PIK3CB |
| ATG2A | PIK3CD |
| ATG3 | PIK3R1 |
| ATG4A | PIK3R2 |
| ATG4B | PIK3R3 |
| ATG5 | PIK3R4 |
| ATG7 | PPP2CA |
| bad | PPP2CB |
| Bcl-2 | PRAP1 |
| BCL2L1 | PRKAA2 |
| BECN1 | PRKACA |
| BNIP3 | PRKACB |
| CAMKK2 | PRKACG |
| Cathepsin B | PRKCD |
| Cathepsin D | PRKCQ |
| Cathepsin L | PTEN |
| CFLAR | RAB1A |
| DAPK2 | RAB39B |
| DAPK3 | RAB7A |
| DEPTOR | RAF1 |
| EIF2AK3 | Ras |
| EIF2AK4 | RB1CC1 |
| EIF2S1 | RHEB |
| GABARAP | RPS6KB1 |
| GABARAPL1 | RRAGB |
| GABARAPL2 | RRAGC |
| GBL | RRAS2 |
| HIF-1 alpha | SH3GLB1 |
| HMGB1 | SNAP29 |
| HRAS | SQSTM1 |
| IGF-I R | STK11 |
| Insulin | STX17 |
| IRE1 | TANK |
| IRS1 | TBK1 |
| IRS2 | TRAF6 |
| KIAA1303 | TSC1 |
| LAMP1 | TSC2 |
| LAMP2 | ULK2 |
| MAP2K1 | UVRAG |
| MAP2K2 | VAMP8 |
| MAP3K7 | VMP1 |
| MAPK1 | WIPI1 |
| MAPK3 | WIPI2 |
04
背景:细胞粘附分子(CAM)是众多介导细胞间或细胞与细胞外基质(ECM)间相互接触和结合分子的统称。粘附分子以受体-配体结合的形式发挥作用,使细胞与细胞间,细胞与基质间,或细胞-基质-细胞间发生粘附,参与细胞的识别,细胞的活化和信号转导,细胞的增殖与分化,细胞的伸展与移动,是免疫应答、炎症发生、凝血、肿瘤转移以及创伤愈合等一系列重要生理和病理过程的分子基础。
货号:AAH-BLG-CAM
靶标数:125
靶标列表:
| ALCAM | ICAM-3 |
| B7-H2 | ICOS |
| B7-H3 | IGSF11 |
| Caspr2 | IGSF4B |
| CD155 | ITGA4 |
| CD2 | ITGA6 |
| CD22 | ITGA8 |
| CD226 | ITGA9 |
| CD274 | ITGAV |
| CD28 | ITGB1 |
| CD34 | ITGB2 |
| CD4 | ITGB7 |
| CD40 | ITGB8 |
| CD40 Ligand | JAM2 |
| CD43 | JAM3 |
| CD45 | JAM-A |
| CD58 | Kilon |
| CD6 | L1CAM |
| CD80 | LFA-1 alpha |
| CD86 | LRRC4 |
| CD8A | LRRC4B |
| CD8B | LRRC4C |
| CD99 | L-Selectin |
| CD99-L2 | MAC-1 |
| CDH15 | MAdCAM-1 |
| CDH4 | MAG |
| Claudin-3 | NCAM-1 |
| Claudin-4 | NCAM2 |
| CLDN1 | Nectin-1 |
| CLDN10 | Nectin-2 |
| CLDN11 | Nectin-3 |
| CLDN14 | Neogenin |
| CLDN15 | Netrin G2 |
| CLDN17 | Neural Cadherin |
| CLDN18 | NFASC |
| CLDN19 | NLGN1 |
| CLDN2 | NLGN2 |
| CLDN23 | NLGN3 |
| CLDN6 | NLGN4X |
| CLDN7 | NrCAM |
| CLDN8 | NRXN3 |
| CLDN9 | NTNG1 |
| CNTNAP1 | P-Cadherin |
| Contactin-1 | PD-1 |
| Contactin-2 | PDCD1LG2 |
| CTLA-4 | PECAM-1 |
| E-Cadherin | P-Selectin |
| ESAM | PTP mu |
| E-Selectin | PTPRF |
| GLG1 | SDC2 |
| HLA-DMA | SDC4 |
| HLA-DMB | SELPLG |
| HLA-DOA | Siglec-1 |
| HLA-DOB | SynCAM |
| HLA-DPA1 | Syndecan-1 |
| HLA-DQA1 | Syndecan-3 |
| HLA-DQA2 | TIGIT |
| HLA-DR | VCAM-1 |
| HLA-DRB1 | VE-Cadherin |
| HLA-DRB3 | Versican |
| HLA-E | VISTA |
| ICAM-1 | VTCN1 |
| ICAM-2 |
05
背景:趋化因子(chemokines):是一类由细胞分泌的小细胞因子或信号蛋白。由于它们具有诱导附近反应细胞定向趋化的能力,因而命名为趋化细胞因子。趋化因子是一个结构相关的细胞因子家族,大多数趋化因子是分子量约10kda的分泌蛋白,其羧基末端的α螺旋结构负责优先结合血管内皮细胞上的蛋白多糖和细胞外基质蛋白。有四个半胱氨酸位于其高度保守的位置。根据两到四个高度保守的N-末端半胱氨酸的数目和间距,趋化因子被分为四个不同的亚家族:CXC、CC、XC、CX3C。
货号:AAH-BLG-CHE
靶标数:175
靶标列表:
| 6Ckine | IKBKG |
| ADCY1 | IL-8 |
| ADCY2 | IP-10 |
| ADCY3 | I-TAC |
| ADCY4 | ITK |
| ADCY5 | JAK3 |
| ADCY6 | Lymphotactin |
| ADCY7 | LYN |
| ADCY8 | MAP2K1 |
| ADCY9 | MAPK1 |
| ADRBK2 | MAPK3 |
| AKT1 | MCP-1 |
| AKT2 | MCP-2 |
| AKT3 | MCP-3 |
| ARB1 | MCP-4 |
| ARRB2 | MDC |
| bad | MIG |
| BCAR1 | MIP 2 |
| BLC | MIP-1 alpha |
| BRAF | MIP-1 beta |
| CCL28 | MIP-1 delta |
| CCL3L1 | MIP-3 alpha |
| CCL4L1 | MIP-3 beta |
| CCR1 | NAP-2 |
| CCR10 | NCF1 |
| CCR3 | NFKB1 |
| CCR4 | NFKBIA |
| CCR5 | NFKBIB |
| CCR6 | NRAS |
| CCR7 | PAK1 |
| CCR8 | PARC |
| CCR9 | PARD3 |
| CDC42 | PF4V1 |
| CHUK | PIK3CA |
| CK beta 8-1 | PIK3CB |
| CRK | PIK3CD |
| CrkL | PIK3CG |
| CTACK | PIK3R1 |
| CX3CR1 | PIK3R2 |
| CXCL14 | PIK3R3 |
| CXCL16 | PIK3R5 |
| CXCR3 | PIK3R6 |
| CXCR4 | Platelet Factor 4 |
| CXCR5 | PLCB1 |
| CXCR6 | PLCB2 |
| DOCK2 | PLCB3 |
| ELMO1 | PLCB4 |
| ENA-78 | PREX1 |
| Eotaxin-1 | PRKACA |
| Eotaxin-2 | PRKACB |
| Eotaxin-3 | PRKACG |
| FAK | PRKCB |
| Fgr | PRKCD |
| Fractalkine | PRKCZ |
| GCP-2 | PXN |
| GNAI1 | PYK2 |
| GNAI2 | RAC1 |
| GNAI3 | RAC2 |
| GNB1 | RAC3 |
| GNB2 | RAF1 |
| GNB3 | RANTES |
| GNB4 | RAP1A |
| GNB5 | RAP1AB |
| GNG11 | Ras |
| GNG12 | RASGRP2 |
| GNG13 | RELA |
| GNG4 | RHOA |
| GNG5 | ROCK1 |
| GNG8 | ROCK2 |
| GNGT1 | SDF-1 |
| GNGT2 | SHC1 |
| GRB2 | SHC2 |
| GRK1 | SOS2 |
| GRK2 | SRC |
| GRK4 | STAT1 |
| GRK5 | STAT2 |
| GRK6 | STAT3 |
| GRK7 | STAT5B |
| GRO alpha | TARC |
| GRO alpha/beta/gamma | TECK |
| GSK3A | TIAM1 |
| GSK3B | VAV1 |
| HCC-1 | VAV2 |
| HCC-4 | VAV3 |
| HCK | WAS |
| HRAS | XCL2 |
| I-309 | XCR1 |
| IKBKB |
06
背景:细胞周期(cell cycle)是指细胞从一次分裂完成开始到下一次分裂结束所经历的全过程,分为间期与分裂期两个阶段。生命是从一代向下一代传递的连续过程,因此是一个不断更新、不断从头开始的过程。细胞的生命开始于产生它的母细胞的分裂, 结束于它的子细胞的形成,或是细胞的自身死亡。通常将子细胞形成作为一次细胞分裂结束的标志,细胞周期是指从一次细胞分裂形成子细胞开始到下一次细胞分裂形成子细胞为止所经历的过程。在这一过程中,细胞的遗传物质复制并均等地分配给两个子细胞。
货号:AAH-BLG-CYC
靶标数:89
靶标列表:
| 14-3-3 beta | CHEK2 |
| 14-3-3 epsilon | Cyclin D1 |
| 14-3-3 eta | E2F1 |
| 14-3-3 gamma | E2F2 |
| 14-3-3 sigma | E2F4 |
| 14-3-3 theta | E2F5 |
| 14-3-3 zeta | EP300 |
| ABL1 | GADD45A |
| ANAPC1 | GADD45B |
| ANAPC13 | GADD45G |
| ANAPC2 | GSK3B |
| ANAPC4 | HDAC1 |
| ATM | HDAC2 |
| ATR | MAD1L1 |
| BUB1 | MAD2L1 |
| BUB3 | MCM5 |
| CBP | MCM7 |
| CCNA1 | MCMP2 |
| CCNA2 | MDM2 |
| CCNB2 | MYC |
| CCND2 | ORC3L |
| CCND3 | p21 |
| CCNE1 | p27/Kip1 |
| CCNE2 | p53 |
| CDC14A | PCNA |
| CDC14B | PLK1 |
| CDC16 | PRKDC |
| CDC2 | PTTG2 |
| CDC23 | RB1 |
| CDC25A | RBL1 |
| CDC25B | RBL2 |
| CDC25C | SKP2 |
| CDC26 | Smad 4 |
| CDC27 | SMAD2 |
| CDC6 | SMAD3 |
| CDK2 | SMC1A |
| CDK4 | STAG1 |
| CDK6 | TFDP1 |
| CDK7 | TFDP2 |
| CDKN1C | TGF beta 1 |
| CDKN2A | TGF beta 2 |
| CDKN2B | TGF beta 3 |
| CDKN2C | TTK |
| CDKN2D | ZBTB17 |
| CHEK1 |
07
背景:细胞因子通过结合细胞表面相应的细胞因子受体而发挥生物学作用。细胞因子与其受体结合后启动复杂的细胞内分子间的相互作用,最终引起细胞基因转录的变化,这一过程称为细胞的信号转导。细胞因子和其受体的结合是细胞因子介导的细胞信号转导的启动刺激。已知的细胞因子受体绝大多数是跨膜蛋白,由胞膜外区、跨膜区和胞浆区组成。胞膜外区为识别结合细胞因子的部位,胞浆区启动受体激活后的信号转导。细胞因子受体根据其结构和信号转导途径可分为I 型细胞因子受体、II 型细胞因子受体、肿瘤坏死因子受体和趋化性细胞因子受体等不同的家族或超家族。
靶数:283
靶标列表:
| 4-1BB | IL-12 p35 |
| 6Ckine | IL-12 p40 |
| Activin A | IL-12 R beta 1 |
| Activin B | IL-12 R beta 2 |
| Activin C | IL-13 |
| Activin R1A | IL-13 R alpha 1 |
| Activin R1B | IL-13 R alpha 2 |
| Activin R2A | IL-15 |
| ACVR1C | IL-15 R alpha |
| ACVR2B | IL-16 |
| ACVRL1 | IL-17 RA |
| ALK-6 | IL-17 RB |
| AMH | IL-17 RC |
| APRIL | IL-17 RE |
| BAFF | IL-17A |
| BAFF R | IL-17B |
| BCMA | IL-17C |
| beta-NGF | IL-17D |
| BLC | IL-17E |
| BMP-10 | IL-17F |
| BMP13 | IL-18 |
| BMP-15 | IL-18 R alpha |
| BMP-2 | IL-18 R beta |
| BMP-3 | IL-19 |
| BMP-3b | IL-2 |
| BMP-4 | IL-2 R alpha |
| BMP-5 | IL-2 R beta |
| BMP-6 | IL-2 R gamma |
| BMP-7 | IL-20 |
| BMP-8 | IL-20 R alpha |
| BMP8A | IL-20 R beta |
| BMP-9 | IL-21 |
| BMPR-IA | IL-21 R |
| BMPR-II | IL-22 |
| Cardiotrophin-1 | IL-22 R |
| CCL28 | IL-23 |
| CCL3L1 | IL-23 R |
| CCL4L1 | IL-24 |
| CCR1 | IL-26 |
| CCR10 | IL-27 |
| CCR3 | IL-28 RA |
| CCR4 | IL-28A |
| CCR5 | IL-28B |
| CCR6 | IL-29 |
| CCR7 | IL-3 |
| CCR8 | IL-3 R alpha |
| CCR9 | IL-31 |
| CCRL1 | IL-31 RA |
| CD27 | IL-33 |
| CD30 | IL-34 |
| CD30 Ligand | IL-36 alpha |
| CD4 | IL-36 beta |
| CD40 | IL-36 gamma |
| CD40 Ligand | IL-36 Ra |
| CD70 | IL-37 |
| CK beta 8-1 | IL-38 |
| CNTF | IL-4 |
| CNTF R alpha | IL-4 R |
| CSF2RB | IL-5 |
| CSH1 | IL-5 R alpha |
| CSH2 | IL-6 |
| CTACK | IL-6 R |
| CX3CR1 | IL-7 |
| CXCL14 | IL-7 R alpha |
| CXCL16 | IL-8 |
| CXCL17 | IL-9 |
| CXCR3 | IL-9 R |
| CXCR4 | INHA |
| CXCR5 | Inhibin beta |
| CXCR6 | IP-10 |
| CXCR7 | I-TAC |
| DcR3 | Leptin |
| DR3 | Leptin R |
| DR6 | LIF |
| EDA-A2 | LIF R alpha |
| EDAR | LIGHT |
| ENA-78 | LTB |
| Eotaxin-1 | Lymphotactin |
| Eotaxin-2 | Lymphotoxin beta R |
| Eotaxin-3 | MCP-1 |
| Erythropoietin | MCP-2 |
| Erythropoietin R | MCP-3 |
| Fas | MCP-4 |
| Fas Ligand | M-CSF |
| Fractalkine | M-CSF R |
| GCP-2 | MDC |
| GCSF | MIG |
| GCSF R | MIP 2 |
| GDF1 | MIP-1 alpha |
| GDF-11 | MIP-1 beta |
| GDF-15 | MIP-1 delta |
| GDF-3 | MIP-3 alpha |
| GDF-5 | MIP-3 beta |
| GDF-7 | MISRII |
| GDF-8 | MPL |
| GDF-9 | NAP-2 |
| GITR | NGFR |
| GITR Ligand | NODAL |
| GM-CSF | Oncostatin M |
| GM-CSF R alpha | Oncostatin M R beta |
| gp130 | Osteoprotegerin |
| GRO alpha | OX40 |
| GRO alpha/beta/gamma | OX40 Ligand |
| Growth hormone 1 | PARC |
| Growth hormone 2 | PF4V1 |
| Growth Hormone R | Platelet Factor 4 |
| HCC-1 | PRLR |
| HCC-4 | Prolactin |
| HVEM | RANK |
| I-309 | RANTES |
| IFN alpha 5 | RELT |
| IFNA10 | SDF-1 |
| IFNA14 | TACI |
| IFNA16 | TARC |
| IFNA17 | TCCR |
| IFNA2 | TECK |
| IFNA21 | TGF beta 1 |
| IFNA4 | TGF beta 2 |
| IFNA6 | TGF beta 3 |
| IFNA7 | TGF-beta RI |
| IFNA8 | TGF-beta RII |
| IFN-alpha / beta R2 | Thrombopoietin |
| IFN-alpha/beta R1 | TNF alpha |
| IFN-beta | TNF beta |
| IFNE | TNF RI |
| IFN-gamma | TNF RII |
| IFN-gamma R1 | TRAIL |
| IFNGR2 | TRAIL R1 |
| IFNW1 | TRAIL R2 |
| IL-1 alpha | TRAIL R3 |
| IL-1 beta | TRAIL R4 |
| IL-1 R1 | TRANCE |
| IL-1 R2 | TROY |
| IL-1 R3 | TSLP |
| IL-1 R4 | TSLP R |
| IL-1 R6 | TWEAK |
| IL-1 Ra | TWEAK R |
| IL-10 | VEGI |
| IL-10 R alpha | XCL2 |
| IL-10 R beta | XCR1 |
| IL-11 | XEDAR |
| IL-11 R alpha | |
08
背景:生长因子(growth factor) 一类通过与特异的、高亲和的细胞膜受体结合,调节细胞生长与其他细胞功能等多效应的多肽类物质。其是由多种细胞分泌,作用于特定的靶细胞,调节细胞分裂、基质合成与组织分化的细胞因子。 [1] 生长因子存在于血小板和各种成体与胚胎组织及大多数培养细胞中,对不同种类细胞具有一定的专一性。通常培养细胞的生长需要多种生长因子顺序的协调作用,肿瘤细胞具有不依赖生长因子的自主性生长的特点。在分泌特点上,生长因子主要属于自分泌(autocrine)和旁分泌(paracrine)。
货号:AAH-BLG-GRO
靶标数:89
靶标列表:
| Activin A | GDF1 |
| Activin B | GDF-11 |
| Activin C | GDF-15 |
| aFGF | GDF-3 |
| Amphiregulin | GDF-5 |
| Artemin | GDF-7 |
| Betacellulin | GDF-8 |
| BMP-10 | GDF-9 |
| BMP13 | GDNF |
| BMP-15 | HB-EGF |
| BMP-2 | HRG-beta1 |
| BMP-3 | IGF-1 |
| BMP-3b | IGF-2 |
| BMP-4 | IGFL2 |
| BMP-5 | IGFL3 |
| BMP-6 | INHA |
| BMP-7 | Inhibin beta |
| BMP-8 | Insulin |
| BMP8A | Lefty-1 |
| BMP-9 | Lefty-A |
| CCN1 | Midkine |
| CCN6 | Neurturin |
| CTGF | NODAL |
| EPGN | NOV |
| Epiregulin | NRG2 |
| FGF Basic | NRG3 |
| FGF-10 | PDGF-AA |
| FGF-11 | PDGF-BB |
| FGF-12 | PDGF-C |
| FGF-13 1B | PDGF-D |
| FGF-16 | Persephin |
| FGF-17 | PLGF |
| FGF-18 | PTN |
| FGF-19 | SF20 |
| FGF-20 | TGF alpha |
| FGF-21 | TGF beta 1 |
| FGF22 | TGF beta 2 |
| FGF-23 | TGF beta 3 |
| FGF-3 | VEGF-A |
| FGF-4 | VEGF-B |
| FGF-5 | VEGF-C |
| FGF-6 | VEGF-D |
| FGF-7 | WISP-1 |
| FGF-8 | WISP2 |
| FGF-9 |